Coverex-AS Komb. may be available in the countries listed below.
Indapamide is reported as an ingredient of Coverex-AS Komb. in the following countries:
Perindopril arginine (a derivative of Perindopril) is reported as an ingredient of Coverex-AS Komb. in the following countries:
International Drug Name Search
Valsartan MK may be available in the countries listed below.
Valsartan is reported as an ingredient of Valsartan MK in the following countries:
International Drug Name Search
Nifedipine Actavis may be available in the countries listed below.
Nifedipine is reported as an ingredient of Nifedipine Actavis in the following countries:
International Drug Name Search
Rhinobudesonide Mylan may be available in the countries listed below.
Budesonide is reported as an ingredient of Rhinobudesonide Mylan in the following countries:
International Drug Name Search
Melanil may be available in the countries listed below.
Atovaquone is reported as an ingredient of Melanil in the following countries:
Proguanil hydrochloride (a derivative of Proguanil) is reported as an ingredient of Melanil in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
In the US, Aldactone (spironolactone systemic) is a member of the following drug classes: aldosterone receptor antagonists, potassium-sparing diuretics and is used to treat Acne, Alopecia, Edema, Heart Failure, High Blood Pressure, Hirsutism, Hypokalemia, Primary Hyperaldosteronism and Primary Hyperaldosteronism Diagnosis.
US matches:
UK matches:
Potassium Canrenoate is reported as an ingredient of Aldactone in the following countries:
Spironolactone is reported as an ingredient of Aldactone in the following countries:
International Drug Name Search
Glossary
| SPC | Summary of Product Characteristics (UK) |
B.H.L. may be available in the countries listed below.
Trihexyphenidyl hydrochloride (a derivative of Trihexyphenidyl) is reported as an ingredient of B.H.L. in the following countries:
International Drug Name Search
Glimestada may be available in the countries listed below.
Glimepiride is reported as an ingredient of Glimestada in the following countries:
International Drug Name Search
Kelfer may be available in the countries listed below.
Deferiprone is reported as an ingredient of Kelfer in the following countries:
International Drug Name Search
Vexib may be available in the countries listed below.
Valdecoxib is reported as an ingredient of Vexib in the following countries:
International Drug Name Search
Doxy-HP may be available in the countries listed below.
Doxycycline monohydrate (a derivative of Doxycycline) is reported as an ingredient of Doxy-HP in the following countries:
International Drug Name Search
Sulfacetamidum may be available in the countries listed below.
Sulfacetamide sodium salt (a derivative of Sulfacetamide) is reported as an ingredient of Sulfacetamidum in the following countries:
International Drug Name Search
Relpax is a brand name of eletriptan, approved by the FDA in the following formulation(s):
No. There is currently no therapeutically equivalent version of Relpax available.
Note: Fraudulent online pharmacies may attempt to sell an illegal generic version of Relpax. These medications may be counterfeit and potentially unsafe. If you purchase medications online, be sure you are buying from a reputable and valid online pharmacy. Ask your health care provider for advice if you are unsure about the online purchase of any medication.
See also: About generic drugs.
Patents are granted by the U.S. Patent and Trademark Office at any time during a drug's development and may include a wide range of claims.
Broncotosil may be available in the countries listed below.
Bromhexine hydrochloride (a derivative of Bromhexine) is reported as an ingredient of Broncotosil in the following countries:
International Drug Name Search
Dolcol may be available in the countries listed below.
Pipemidic Acid is reported as an ingredient of Dolcol in the following countries:
Pipemidic Acid trihydrate (a derivative of Pipemidic Acid) is reported as an ingredient of Dolcol in the following countries:
International Drug Name Search
Atacand Zid may be available in the countries listed below.
Candesartan cilexetil (a derivative of Candesartan) is reported as an ingredient of Atacand Zid in the following countries:
Hydrochlorothiazide is reported as an ingredient of Atacand Zid in the following countries:
International Drug Name Search
Anabolin may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Nandrolone 17ß-decanoate (a derivative of Nandrolone) is reported as an ingredient of Anabolin in the following countries:
Nandrolone 17ß-phenpropionate (a derivative of Nandrolone) is reported as an ingredient of Anabolin in the following countries:
International Drug Name Search
Fleboside may be available in the countries listed below.
Carbazochrome is reported as an ingredient of Fleboside in the following countries:
Troxerutin is reported as an ingredient of Fleboside in the following countries:
International Drug Name Search
Myomergin may be available in the countries listed below.
Methylergometrine maleate (a derivative of Methylergometrine) is reported as an ingredient of Myomergin in the following countries:
International Drug Name Search
Menalmina may be available in the countries listed below.
Chlorhexidine digluconate (a derivative of Chlorhexidine) is reported as an ingredient of Menalmina in the following countries:
International Drug Name Search
Migofen may be available in the countries listed below.
Pizotifen is reported as an ingredient of Migofen in the following countries:
International Drug Name Search
Captopril-EG may be available in the countries listed below.
Captopril is reported as an ingredient of Captopril-EG in the following countries:
International Drug Name Search
Pentozed may be available in the countries listed below.
Domperidone is reported as an ingredient of Pentozed in the following countries:
Pantoprazole is reported as an ingredient of Pentozed in the following countries:
International Drug Name Search
Fluticasonpropionaat Ratiopharm may be available in the countries listed below.
Fluticasone propionate (a derivative of Fluticasone) is reported as an ingredient of Fluticasonpropionaat Ratiopharm in the following countries:
International Drug Name Search
Béconase may be available in the countries listed below.
Beclometasone is reported as an ingredient of Béconase in the following countries:
Beclometasone 17α,21-dipropionate (a derivative of Beclometasone) is reported as an ingredient of Béconase in the following countries:
International Drug Name Search
Fozinopril may be available in the countries listed below.
Fosinopril is reported as an ingredient of Fozinopril in the following countries:
International Drug Name Search
Cefovex may be available in the countries listed below.
Cefuroxime is reported as an ingredient of Cefovex in the following countries:
International Drug Name Search
Rec.INN
0024143-17-7
C18-H17-Cl-N2-O2
328
Anxiolytic agent
Benzodiazepine derivative
Oxazolo[3,2-d][1,4]benzodiazepin-6(5H)-one, 10-chloro-2,3,7,11b-tetrahydro-2-methyl-11b-phenyl-
International Drug Name Search
Glossary
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Tavex may be available in the countries listed below.
Venlafaxine is reported as an ingredient of Tavex in the following countries:
International Drug Name Search
Ibubeta may be available in the countries listed below.
Ibuprofen is reported as an ingredient of Ibubeta in the following countries:
International Drug Name Search
Tremblex may be available in the countries listed below.
Dexetimide is reported as an ingredient of Tremblex in the following countries:
Dexetimide hydrochloride (a derivative of Dexetimide) is reported as an ingredient of Tremblex in the following countries:
International Drug Name Search
Métergoline may be available in the countries listed below.
Métergoline (DCF) is also known as Metergoline (Rec.INN)
International Drug Name Search
Glossary
| DCF | Dénomination Commune Française |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
Bixelor-C may be available in the countries listed below.
Cefaclor monohydrate (a derivative of Cefaclor) is reported as an ingredient of Bixelor-C in the following countries:
International Drug Name Search
Pevazol may be available in the countries listed below.
Econazole nitrate (a derivative of Econazole) is reported as an ingredient of Pevazol in the following countries:
International Drug Name Search
Landstav may be available in the countries listed below.
Stavudine is reported as an ingredient of Landstav in the following countries:
International Drug Name Search
Dormire may be available in the countries listed below.
Midazolam hydrochloride (a derivative of Midazolam) is reported as an ingredient of Dormire in the following countries:
International Drug Name Search
Uractone may be available in the countries listed below.
Spironolactone is reported as an ingredient of Uractone in the following countries:
International Drug Name Search
Sinvastacor may be available in the countries listed below.
Simvastatin is reported as an ingredient of Sinvastacor in the following countries:
International Drug Name Search
Urospes-N may be available in the countries listed below.
Norfloxacin is reported as an ingredient of Urospes-N in the following countries:
International Drug Name Search
Ventolair Easi-Breathe may be available in the countries listed below.
Beclometasone 17α,21-dipropionate (a derivative of Beclometasone) is reported as an ingredient of Ventolair Easi-Breathe in the following countries:
International Drug Name Search
Petilin may be available in the countries listed below.
Valproic Acid sodium (a derivative of Valproic Acid) is reported as an ingredient of Petilin in the following countries:
International Drug Name Search
Generic Name: hydrocodone and ibuprofen (hye dro KOE done and eye byoo PRO fen)
Brand Names: Ibudone, Reprexain, Vicoprofen
Hydrocodone is in a group of drugs called narcotic pain relievers.
Ibuprofen is in a group of drugs called nonsteroidal anti-inflammatory drugs (NSAIDs). Ibuprofen works by reducing hormones that cause inflammation and pain in the body.
The combination of hydrocodone and ibuprofen is used short-term to relieve severe pain. This medication is not for treating arthritis pain.
Hydrocodone and ibuprofen may also be used for other purposes not listed in this medication guide.
Ibuprofen can increase your risk of heart attack or stroke. Do not use this medicine just before or after having heart bypass surgery (also called coronary artery bypass graft, or CABG). Seek emergency medical help if you have chest pain, weakness, shortness of breath, slurred speech, or problems with vision or balance.
Ibuprofen can also increase your risk of serious effects on the stomach or intestines. These conditions can be fatal and can occur without warning at any time while you are taking ibuprofen. Call your doctor at once if you have black, bloody, or tarry stools, or if you cough up blood or vomit that looks like coffee grounds.
Tell your doctor if the medicine seems to stop working as well in relieving your pain.
Taking ibuprofen can increase your risk of life-threatening heart or circulation problems, including heart attack or stroke. Do not use this medicine just before or after having heart bypass surgery (also called coronary artery bypass graft, or CABG).
Ibuprofen can also increase your risk of serious effects on the stomach or intestines, including bleeding or perforation (forming of a hole). These conditions can be fatal and can occur without warning at any time while you are taking ibuprofen.
Before using hydrocodone and ibuprofen, tell your doctor if you have:
heart disease, congestive heart failure, high blood pressure, or a history of heart attack, stroke, or blood clot;
asthma or other breathing disorders;
a history of head injury or brain tumor;
stomach or intestinal disorder, history of stomach ulcer or bleeding;
underactive thyroid, Addison's disease or other adrenal gland disorder;
curvature of the spine;
an enlarged prostate or problems with urination; or
mental illness or a history of drug or alcohol addiction.
If you have any of these conditions, you may not be able to use hydrocodone and ibuprofen, or you may need a dosage adjustment or special tests during treatment.
Older adults may be more sensitive to the effects of this medicine.
Take this medication exactly as it was prescribed for you. Do not take it in larger amounts, or use it for longer than recommended by your doctor. Follow the directions on your prescription label. Tell your doctor if the medicine seems to stop working as well in relieving your pain.
If you need to have any type of surgery, tell the surgeon ahead of time that you are using hydrocodone and ibuprofen.
Keep track of how many tablets have been used from each new bottle of this medicine. Hydrocodone is a drug of abuse and you should be aware if any person in the household is using this medicine improperly or without a prescription.
See also: Reprexain dosage (in more detail)
Since hydrocodone and ibuprofen is taken as needed, you may not be on a dosing schedule. If you are taking the medication regularly, take the missed dose as soon as you remember. If it is almost time for the next dose, skip the missed dose and wait until your next regularly scheduled dose. Do not use extra medicine to make up the missed dose.
Overdose symptoms may include extreme drowsiness, nausea, vomiting, dark urine, jaundice (yellowing of the skin or eyes), black or bloody stools, coughing up blood, urinating less than usual or not at all, confusion, ringing in your ears, pinpoint pupils, weak pulse, slow heart rate, blue lips, shallow breathing, or fainting.
chest pain, weakness, shortness of breath, slurred speech, problems with vision or balance;
sudden numbness or weakness, headache, confusion, or problems with vision, speech, or balance;
black, bloody, or tarry stools, coughing up blood or vomit that looks like coffee grounds;
swelling or rapid weight gain;
shallow breathing, slow heartbeat;
confusion, feeling light-headed, fainting;
easy bruising or bleeding;
nausea, stomach pain, loss of appetite, itching, dark urine, clay-colored stools, jaundice (yellowing of the skin or eyes);
severe blistering, peeling, and red skin rash; or
fever, headache, neck stiffness, chills, increased sensitivity to light, purple spots on the skin, and/or seizure (convulsions).
Less serious side effects may include:
headache, dizziness, drowsiness;
mild nausea, vomiting, upset stomach, constipation, diarrhea;
blurred vision; or
dry mouth.
This is not a complete list of side effects and others may occur. Tell your doctor about any unusual or bothersome side effect. You may report side effects to FDA at 1-800-FDA-1088.
Before taking this medication, tell your doctor if you are using any of the following drugs:
antidepressants such as amitriptyline (Elavil, Etrafon) or imipramine (Janimine, Tofranil);
an MAO inhibitor such as isocarboxazid (Marplan), phenelzine (Nardil), selegiline (Eldepryl, Emsam), or tranylcypromine (Parnate);
aspirin or other NSAIDs (non-steroidal anti-inflammatory drugs) such as diclofenac (Voltaren), etodolac (Lodine), indomethacin (Indocin), naproxen (Aleve, Naprosyn), and others;
an ACE inhibitor such as benazepril (Lotensin), captopril (Capoten), fosinopril (Monopril), enalapril (Vasotec), lisinopril (Prinivil, Zestril), quinapril (Accupril), and others;
lithium (Eskalith, Lithobid);
a bronchodilator (such as Atrovent, Spiriva), diuretics (water pills), steroid medicines, or blood thinners;
methotrexate (Rheumatrex, Trexall);
an injected narcotic medication such as pentazocine (Talwin), butorphanol (Stadol), or nalbuphine Nubain);
atropine (Donnatal), dimenhydrinate (Dramamine), or scopolamine (Transderm-Scop); or
bowel or bladder medications such as dicyclomine (Bentyl), hyoscyamine (Anaspaz, Cystospaz, Levsin), tolterodine (Detrol) and others.
This list is not complete and there may be other drugs that can interact with hydrocodone and ibuprofen. Tell your doctor about all the prescription and over-the-counter medications you use. This includes vitamins, minerals, herbal products, and drugs prescribed by other doctors. Do not start using a new medication without telling your doctor.
See also: Reprexain side effects (in more detail)
Antitrom may be available in the countries listed below.
Acenocoumarol is reported as an ingredient of Antitrom in the following countries:
International Drug Name Search
Ritaroks may be available in the countries listed below.
Aluminium Hydroxide is reported as an ingredient of Ritaroks in the following countries:
Magnesium Hydroxide is reported as an ingredient of Ritaroks in the following countries:
International Drug Name Search
Omatropina may be available in the countries listed below.
Homatropine Hydrobromide is reported as an ingredient of Omatropina in the following countries:
International Drug Name Search
Hypromellose Bournonville may be available in the countries listed below.
Hypromellose is reported as an ingredient of Hypromellose Bournonville in the following countries:
International Drug Name Search
Pethidine BP may be available in the countries listed below.
Pethidine hydrochloride (a derivative of Pethidine) is reported as an ingredient of Pethidine BP in the following countries:
International Drug Name Search
Cephazolin Sodium may be available in the countries listed below.
Cefazolin sodium salt (a derivative of Cefazolin) is reported as an ingredient of Cephazolin Sodium in the following countries:
International Drug Name Search
Lansoprazolo Hexal may be available in the countries listed below.
Lansoprazole is reported as an ingredient of Lansoprazolo Hexal in the following countries:
International Drug Name Search
In some countries, this medicine may only be approved for veterinary use.
In the US, Amiodarone (amiodarone systemic) is a member of the drug class group III antiarrhythmics and is used to treat Arrhythmia, Ventricular Fibrillation and Ventricular Tachycardia.
US matches:
UK matches:
Rec.INN
C01BD01
0001951-25-3
C25-H29-I2-N-O3
645
Coronary vasodilator
Methanone, (2-butyl-3-benzofuranyl)[4-[2-(diethylamino)ethoxy]-3,5-diiodophenyl]-
International Drug Name Search
Glossary
| BAN | British Approved Name |
| BANM | British Approved Name (Modified) |
| DCF | Dénomination Commune Française |
| DCIT | Denominazione Comune Italiana |
| IS | Inofficial Synonym |
| JAN | Japanese Accepted Name |
| OS | Official Synonym |
| PH | Pharmacopoeia Name |
| Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
| SPC | Summary of Product Characteristics (UK) |
| USAN | United States Adopted Name |
Calject CBG may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Calcium Borogluconate is reported as an ingredient of Calject CBG in the following countries:
International Drug Name Search
Metformina UR may be available in the countries listed below.
Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Metformina UR in the following countries:
International Drug Name Search
Dilaprost may be available in the countries listed below.
Finasteride is reported as an ingredient of Dilaprost in the following countries:
International Drug Name Search
E.M.S. Bloat Treatment may be available in the countries listed below.
In some countries, this medicine may only be approved for veterinary use.
Dimeticone is reported as an ingredient of E.M.S. Bloat Treatment in the following countries:
International Drug Name Search
Adco-Cefazolin may be available in the countries listed below.
Cefazolin sodium salt (a derivative of Cefazolin) is reported as an ingredient of Adco-Cefazolin in the following countries:
International Drug Name Search
Metoprolol Atid may be available in the countries listed below.
Metoprolol tartrate (a derivative of Metoprolol) is reported as an ingredient of Metoprolol Atid in the following countries:
International Drug Name Search
Vitamina B12 Ecar may be available in the countries listed below.
Cyanocobalamin is reported as an ingredient of Vitamina B12 Ecar in the following countries:
International Drug Name Search
Apo-Azathioprine may be available in the countries listed below.
Azathioprine is reported as an ingredient of Apo-Azathioprine in the following countries:
International Drug Name Search
Cyclopentolate Hydrochloride (BANM, JAN) is known as Cyclopentolate in the US.
International Drug Name Search
Glossary
| BANM | British Approved Name (Modified) |
| JAN | Japanese Accepted Name |
In the US, Psoriderm is a member of the drug class miscellaneous topical agents and is used to treat Dermatitis, Psoriasis and Seborrheic Dermatitis.
Clobetasol 17α-propionate (a derivative of Clobetasol) is reported as an ingredient of Psoriderm in the following countries:
International Drug Name Search
Predni H injekt may be available in the countries listed below.
Prednisolone 21-acetate (a derivative of Prednisolone) is reported as an ingredient of Predni H injekt in the following countries:
International Drug Name Search
Novphyllin may be available in the countries listed below.
Aminophylline is reported as an ingredient of Novphyllin in the following countries:
International Drug Name Search
Hisporan may be available in the countries listed below.
Mequitazine is reported as an ingredient of Hisporan in the following countries:
International Drug Name Search
Songar may be available in the countries listed below.
Triazolam is reported as an ingredient of Songar in the following countries:
International Drug Name Search
Cicloplegico may be available in the countries listed below.
Cyclopentolate hydrochloride (a derivative of Cyclopentolate) is reported as an ingredient of Cicloplegico in the following countries:
International Drug Name Search
Zonal may be available in the countries listed below.
Eperisone hydrochloride (a derivative of Eperisone) is reported as an ingredient of Zonal in the following countries:
International Drug Name Search
Temporarily relieving pain from mouth and gum irritations (eg, caused by mouth sores and ulcers, canker sores, injuries).
OraMagic Plus Suspension in a local anesthetic. It works by numbing sensitive and painful areas.
Contact your doctor or health care provider right away if any of these apply to you.
Some medical conditions may interact with OraMagic Plus Suspension. Tell your doctor or pharmacist if you have any medical conditions, especially if any of the following apply to you:
Some MEDICINES MAY INTERACT with OraMagic Plus Suspension. Because little, if any, of OraMagic Plus Suspension is absorbed into the blood, the risk of it interacting with another medicine is low.
Ask your health care provider if OraMagic Plus Suspension may interact with other medicines that you take. Check with your health care provider before you start, stop, or change the dose of any medicine.
Use OraMagic Plus Suspension as directed by your doctor. Check the label on the medicine for exact dosing instructions.
Ask your health care provider any questions you may have about how to use OraMagic Plus Suspension.
All medicines may cause side effects, but many people have no, or minor, side effects. No COMMON side effects have been reported with this product. Seek medical attention right away if any of these SEVERE side effects occur:
Severe allergic reactions (rash; hives; itching; difficulty breathing; tightness in the chest; swelling of the mouth, face, lips, or tongue); mouth burning, irritation, redness, swelling, or tenderness.
This is not a complete list of all side effects that may occur. If you have questions about side effects, contact your health care provider. Call your doctor for medical advice about side effects. To report side effects to the appropriate agency, please read the Guide to Reporting Problems to FDA.
See also: OraMagic Plus side effects (in more detail)
Contact 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center, or emergency room immediately. OraMagic Plus Suspension may cause harm if more than is used for pain is swallowed. Symptoms may include blue skin or lips; trouble breathing.
Store OraMagic Plus Suspension at room temperature, between 59 and 86 degrees F (15 and 30 degrees C). OraMagic Plus Suspension may be stored in the refrigerator to improve taste. Do not freeze. Throw away any mixed medicine that has not been used after 2 weeks. Store away from heat, moisture, and light. Keep OraMagic Plus Suspension out of the reach of children and away from pets.
This information is a summary only. It does not contain all information about OraMagic Plus Suspension. If you have questions about the medicine you are taking or would like more information, check with your doctor, pharmacist, or other health care provider.
Verapamilo may be available in the countries listed below.
Verapamil is reported as an ingredient of Verapamilo in the following countries:
Verapamil hydrochloride (a derivative of Verapamil) is reported as an ingredient of Verapamilo in the following countries:
International Drug Name Search
Ferrobest may be available in the countries listed below.
Iron Polymaltose is reported as an ingredient of Ferrobest in the following countries:
International Drug Name Search
Menaderm Otologico may be available in the countries listed below.
Beclometasone 17α,21-dipropionate (a derivative of Beclometasone) is reported as an ingredient of Menaderm Otologico in the following countries:
Clioquinol is reported as an ingredient of Menaderm Otologico in the following countries:
International Drug Name Search
Seleparina may be available in the countries listed below.
Nadroparin Calcium is reported as an ingredient of Seleparina in the following countries:
International Drug Name Search
Ceftal may be available in the countries listed below.
Cefuroxime is reported as an ingredient of Ceftal in the following countries:
International Drug Name Search
oh-FAT-oo-moo-mab
In the U.S.
Available Dosage Forms:
Pharmacologic Class: Monoclonal Antibody
Ofatumumab injection is used to treat a type of cancer of the white blood cells called chronic lymphocytic leukemia (CLL). ofatumumab is used in patients with CLL who have already been treated with other medicines (e.g., alemtuzumab, fludarabine) that did not work well.
Ofatumumab interferes with the growth of cancer cells, which are eventually destroyed by the body. Since the growth of normal body cells may also be affected by ofatumumab, other unwanted effects will also occur. Some of these may be serious and must be reported to your doctor. Some unwanted effects, such as a skin rash, may not be serious but may cause concern. Some of the unwanted effects do not occur until months or years after the medicine is used.
Before you begin treatment with ofatumumab, you and your doctor should talk about the good ofatumumab will do as well as the risks of using it.
ofatumumab is available only with your doctor's prescription.
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For ofatumumab, the following should be considered:
Tell your doctor if you have ever had any unusual or allergic reaction to ofatumumab or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Appropriate studies have not been performed on the relationship of age to the effects of ofatumumab injection in the pediatric population. Safety and efficacy have not been established.
Although appropriate studies on the relationship of age to the effects of ofatumumab injection have not been performed in the geriatric population, no geriatric-specific problems have been documented to date.
| Pregnancy Category | Explanation | |
|---|---|---|
| All Trimesters | C | Animal studies have shown an adverse effect and there are no adequate studies in pregnant women OR no animal studies have been conducted and there are no adequate studies in pregnant women. |
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. Tell your healthcare professional if you are taking any other prescription or nonprescription (over-the-counter [OTC]) medicine.
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
The presence of other medical problems may affect the use of ofatumumab. Make sure you tell your doctor if you have any other medical problems, especially:
You will receive ofatumumab while you are in a hospital or cancer treatment center. A nurse or other trained health professional will give you ofatumumab. ofatumumab is given through a needle placed in one of your veins.
Ofatumumab needs to be given slowly, so the needle will remain in place for at least an hour. You may also receive medicines to help prevent allergic reactions.
It is very important that your doctor check your progress at regular visits to make sure ofatumumab is working properly and to check for unwanted effects. Blood tests may be needed to check for unwanted effects.
ofatumumab may cause chest pain; fever; chills; itching; hives; flushing of the face; rash; dizziness, fainting, or lightheadedness; troubled breathing; or swelling of the face, tongue, and throat within a few hours after you receive it. Check with your doctor or nurse right away if you have any of these symptoms.
Ofatumumab can temporarily lower the number of white blood cells in your blood, increasing the chance of getting an infection. It can also lower the number of platelets, which are necessary for proper blood clotting. If this occurs, there are certain precautions you can take, especially when your blood count is low, to reduce the risk of infection or bleeding:
ofatumumab may increase your risk of developing a serious and rare brain infection called progressive multifocal leukoencephalopathy (PML). Check with your doctor right away if you are having more than one of these symptoms: vision changes, loss of coordination, clumsiness, memory loss, difficulty speaking or understanding what others say, and weakness in the legs.
Check with your doctor immediately if you have any symptoms of liver problems including skin and eyes turning yellow, dark brown-colored urine, right-sided abdominal or stomach pain, fever, or severe tiredness.
While you are being treated with ofatumumab, do not have any immunizations (vaccines) without your doctor's approval. Live virus vaccines should not be given with ofatumumab or soon after you receive it.
Along with its needed effects, a medicine may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.
Check with your doctor or nurse immediately if any of the following side effects occur:
Some side effects may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:
Other side effects not listed may also occur in some patients. If you notice any other effects, check with your healthcare professional.
Call your doctor for medical advice about side effects. You may report side effects to the FDA at 1-800-FDA-1088.
See also: ofatumumab Intravenous side effects (in more detail)
The information contained in the Thomson Reuters Micromedex products as delivered by Drugs.com is intended as an educational aid only. It is not intended as medical advice for individual conditions or treatment. It is not a substitute for a medical exam, nor does it replace the need for services provided by medical professionals. Talk to your doctor, nurse or pharmacist before taking any prescription or over the counter drugs (including any herbal medicines or supplements) or following any treatment or regimen. Only your doctor, nurse, or pharmacist can provide you with advice on what is safe and effective for you.
The use of the Thomson Reuters Healthcare products is at your sole risk. These products are provided "AS IS" and "as available" for use, without warranties of any kind, either express or implied. Thomson Reuters Healthcare and Drugs.com make no representation or warranty as to the accuracy, reliability, timeliness, usefulness or completeness of any of the information contained in the products. Additionally, THOMSON REUTERS HEALTHCARE MAKES NO REPRESENTATION OR WARRANTIES AS TO THE OPINIONS OR OTHER SERVICE OR DATA YOU MAY ACCESS, DOWNLOAD OR USE AS A RESULT OF USE OF THE THOMSON REUTERS HEALTHCARE PRODUCTS. ALL IMPLIED WARRANTIES OF MERCHANTABILITY AND FITNESS FOR A PARTICULAR PURPOSE OR USE ARE HEREBY EXCLUDED. Thomson Reuters Healthcare does not assume any responsibility or risk for your use of the Thomson Reuters Healthcare products.
